Cynosure

Clayton, Dubilier & Rice agreed to buy Cynosure LLC from Hologic Inc. for $205 million cash. Cynosure makes aesthetic treatment systems.

Hologic's Cynosure division signed an agreement with Porter Instrument, a business unit of Parker Hannifin, for exclusive distribution rights in the US and Canada to Porter Instrument's nitrous oxide and oxygen system, Nitronox.

Hologic has signed a definitive agreement to acquire all outstanding shares of Cynosure for $66.00 per share in cash, corresponding to an equity value of approximately $1.65 billion and an enterprise value of $1.44 billion net of cash.